4D Molecular Therapeutics, Inc. (NASDAQ:FDMT) Receives Consensus Recommendation of “Buy” from Analysts
4D Molecular Therapeutics, Inc. (NASDAQ:FDMT – Get Free Report) has received a consensus rating of “Buy” from the ten research firms that are presently covering the company, MarketBeat reports. Ten research analysts have rated the stock with a buy recommendation. The average 12 month price target among brokerages that have issued a report on the […]
More Stories
Guy Gosselin Sells 22,500 Shares of Agnico Eagle Mines Limited (TSE:AEM) Stock
Agnico Eagle Mines Limited (TSE:AEM – Get Free Report) (NYSE:AEM) Senior Officer Guy Gosselin sold 22,500 shares of the stock...
Challenger Energy Group (LON:CEG) Shares Up 9.1% – What’s Next?
Shares of Challenger Energy Group PLC (LON:CEG – Get Free Report) shot up 9.1% during mid-day trading on Friday ....
Sage Capital Advisors llc Raises Stock Holdings in Chevron Co. (NYSE:CVX)
Sage Capital Advisors llc grew its position in Chevron Co. (NYSE:CVX – Free Report) by 1.2% during the fourth quarter,...
Tilia Fiduciary Partners Inc. Purchases 1,608 Shares of Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT)
Tilia Fiduciary Partners Inc. lifted its position in Vanguard Intermediate-Term Corporate Bond ETF (NASDAQ:VCIT – Free Report) by 10.0% during...
Lowe’s Companies, Inc. (NYSE:LOW) Shares Purchased by Tilia Fiduciary Partners Inc.
Tilia Fiduciary Partners Inc. lifted its stake in Lowe’s Companies, Inc. (NYSE:LOW – Free Report) by 2.8% in the fourth...
The Greenbrier Companies, Inc. (NYSE:GBX) to Issue Quarterly Dividend of $0.30
The Greenbrier Companies, Inc. (NYSE:GBX – Get Free Report) declared a quarterly dividend on Friday, January 10th,Wall Street Journal reports....